This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Moderate. These medicines may cause some risk when taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Phenytoin interferes with the action of the neuromuscular blocking agent.
What might happen:
There might be a decreased effectiveness of the neuromuscular blocking agent.
What you should do about this interaction:
Make sure your healthcare professionals (e.g. doctor or pharmacist) knows that you are taking medicine for seizures.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicines before checking with them first.
1.Chen J Kim YD Dubois M Kammerer W Macnamara TE. The increased requirement of pancuronium in neurosurgical patients receiving Dilantin chronically. Anesthesiology Sept 1983;59(3):A288.
2.Ornstein E, Matteo RS, Young WL, Diaz J. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985 Sep;63(3):294-8.
3.Liberman BA, Norman P, Hardy BG. Pancuronium-phenytoin interaction: a case of decreased duration of neuromuscular blockade. Int J Clin Pharmacol Ther Toxicol 1988 Aug;26(8):371-4.
4.Hickey DR, Sangwan S, Bevan JC. Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient. Anaesthesia 1988 Sep;43(9):757-9.
5.Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987 Aug;67(2):191-6.
6.NORRIS FH Jr, COLELLA J, MCFARLIN D. EFFECT OF DIPHENYLHYDANTOIN ON NEUROMUSCULAR SYNAPSE. Neurology 1964 Sep;14:869-76.
7.Gandhi IC, Jindal MN, Patel VK. Mechaism of neuromuscular blockade with some antiepileptic drugs. Arzneimittelforschung 1976 Feb;26(2):258-61.
8.Soriano SG, Sullivan LJ, Venkatakrishnan K, Greenblatt DJ, Martyn JA. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth 2001 Feb;86(2):223-9.
9.Gough JD, Smith A, Wise CC. Phenytoin-induced resistance to vecuronium. Anaesthesia 1989 Jun;44(6):520.
10.Kumar CM, Lawler PG. Phenytoin-induced resistance to vecuronium. Anaesthesia 1989 Mar;44(3):263-4.